Occlusions Prompt CABG Medical To Halt Holly Graft Trial

CABG Medical will spend $6 mil. to $8 mil. in 2006 in an attempt to put development of the Holly Graft (HGS) drug-eluting coronary bypass system back on track

More from Archive

More from Medtech Insight